Evidence map›Paper›PMID 26863470›Full record

ArticleJournal of visualized experiments : JoVE2016

Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens.

Paul Johnson, Ellen J Beswick, Celia Chao, Don W Powell, Mark R Hellmich, Iryna V Pinchuk

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Paul JohnsonSurgery, University of Texas Medical Branch.
Ellen J BeswickMolecular Genetics and Microbiology, University of New Mexico.
Celia ChaoSurgery, University of Texas Medical Branch.
Don W PowellInternal Medicine, University of Texas Medical Branch.
Mark R HellmichSurgery, University of Texas Medical Branch.
Iryna V PinchukInternal Medicine, University of Texas Medical Branch; ivpinchu@utmb.edu.
The University of Texas Medical Branch at Galveston · USUniversity of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
SURGICAL TRAINING IN GASTROINTESTINAL ENDOCRINOLOGYT32DK007639 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RADHAKRISHNAN, RAVI S. · 1992 to 2022
$3.6M
Role of Hydrogen Sulfide in Colorectal TumorsR01CA175803 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI HELLMICH, MARK R, SZABO, CSABA · 2014 to 2018
$1.5M
Regulatory role of CD90+ stromal cells in Th1/Th17 activity in Crohn's DiseaseR01DK103150 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PINCHUK, IRYNA V · 2014 to 2017
$1.4M
University of New Mexico Clinical and Translational Science CenterKL2TR000089 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$909k
Bombesin-Activated Carcinoma Associated Fibroblasts in Colorectal CancerK08CA125209 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI CHAO, CELIA · 2009 to 2013
$643k
NCATS NIH HHS 8UL1TR000071NCATS NIH HHS KL2 TR000089NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1 TR001449NCI NIH HHS K08 CA125209NCI NIH HHS K08CA125209NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA175803NCI NIH HHS R01CA175803NIDDK NIH HHS 1R01DK103150-01A1NIDDK NIH HHS R01 DK103150NIDDK NIH HHS T32 DK007639
6 · The paper itself

Abstract

Fibroblasts/myofibroblasts (MFs) have been gaining increasing attention for their role in pathogenesis and their contributions to both wound healing and promotion of the tumor microenvironment. While there are currently many techniques for the isolation of MFs from gastrointestinal (GI) tissues, this protocol introduces a novel element of isolation of these stromal cells from frozen tissue. Freezing GI tissue specimens not only allows the researcher to acquire samples from worldwide collaborators, biobanks, and commercial vendors, it also permits the delayed processing of fresh samples. The described protocol will consistently yield characteristic spindle-shaped cells with the MF phenotype that express the markers CD90, α-SMA and vimentin. As these cells are derived from patient samples, the use of primary cells also confers the benefit of closely mimicking MFs from disease states-namely cancer and inflammatory bowel diseases. This technique has been validated in gastric, small bowel, and colonic MF primary culture generation. Primary MF cultures can be used in a vast array of experiments over a number of passage and their purity assessed by both immunocytochemistry and flow cytometry analysis.

Indexed as

ActinsBiomarkersCell Culture TechniquesColonFibroblastsFlow CytometryFreezingHumansImmunohistochemistryIntestine, SmallMyofibroblastsPhenotypeStromal CellsThy-1 AntigensVimentinACTA2 protein, humanActinsBiomarkersThy-1 AntigensVimentin

Identifiers

PMID26863470
PMCPMC4781712
OpenAlexW2260502194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.